News
Notably, IFT20 clusters with TCRs at the immune synapse and associates with the ζ- and ɛ-chains of CD3 in response to TCR engagement. TCR–CD3 complex assembly is initiated in the endoplasmic ...
T cell activation requires a T cell receptor (TCR) to recognize its cognate peptide in the context of an MHC molecule. In addition, the association of CD3 with the TCR–peptide–MHC complex ...
11,12 (8) Synthetic TCR antigen receptor/HLA-independent TCR (STAR/HIT) constructs retain the full complex of CD3 signaling but also have high antigen sensitivity via the fusion of an antibody binding ...
that consists of a soluble TCR targeting gp100 expressed on cancer cells fused to a protein that binds CD3 receptors on lymphocytes – as a treatment for unresectable or metastatic uveal melanoma.
1mon
GlobalData on MSNMedigene and EpimAb to develop T cell engagers for solid tumoursThe partnership leverages the sensitive, specific and safe (3S) TCR characterisation and generation capabilities of Medigene ...
CD3E, along with CD3-gamma, CD3-delta, CD3-zeta, and T-cell receptor (TCR) alpha/beta or gamma/delta heterodimers, forms the TCR-CD3 complex. This complex is crucial for coupling antigen ...
A diagnostic algorithm is shown in Figure 1. After performing the initial dietary and serologic evaluations, the following studies, as discussed in the ensuing sections, are recommended to confirm ...
The company's T-cell receptor (TCR) technology has led to the development ... cancer antigens and kill malignant cells through an anti-CD3 immune-activating effector function.
Preclinical data for a novel LY6G6D x CD3 bispecific T-cell engager and 4) Preclinical data for a novel TCR based bispecific platform. Details for the presentations are as follows: EMB-01 EGFR x ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results